Home › Post-COVID Conditions (Long COVID) › Georgia
Post-COVID Conditions (Long COVID) clinical trials in Georgia
11 studies for Post-COVID Conditions (Long COVID) are looking for participants at sites in Georgia.
Cities in Georgia
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Balanced Life Health Care Solutions/SKYCRNG ( Site 3713), Lawrenceville
- Renew Health Clinical Research ( Site 3760), Snellville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06667700A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
- The Hope Clinic of Emory University, Decatur
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 64 · All sexes · Updated Oct 2, 2026 · NCT07536308A Study of COVID-19 Vaccine(s) in Children and Adults
- AGILE Clinical Research Trials, LLC, Atlanta
RecruitingPhase 3Healthy volunteers welcome
Ages 5 and older · All sexes · Updated Sep 28, 2026 · NCT07798648A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Velocity Clinical Research, Savannah, Savannah
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- Emory University, Atlanta
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06631287A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- The Hope Clinic of Emory University, Decatur
- Javara - Privia Medical Group Georgia - Fayetteville, Fayetteville
- Coastal Heritage Clinical Research, Hinesville
- and 1 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT06679140A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- GSK Investigational Site, Stockbridge
RecruitingPhase 1
Ages 65 to 85 · All sexes · Updated Jun 30, 2026 · NCT07464314Arginine Replacement Therapy in COVID-19
- Children's Healthcare of Atlanta (CHOA), Arthur M. Blank, Atlanta
RecruitingPhase 2
Ages 3 to 21 · All sexes · Updated Apr 15, 2026 · NCT05855330A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
- CenExel, Atlanta
- CenExel, Decatur
RecruitingPhase 4Healthy volunteers welcome
6 Months · All sexes · Updated Mar 27, 2026 · NCT06585241EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
RecruitingPhase 3
Ages 0 to 17 · All sexes · Updated Jul 17, 2025 · NCT05261139Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- Augusta University, Augusta
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 12, 2024 · NCT02735707From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.